Mr. Rupert Christopher Soames has been the Chairman of the company since September 2023. Previously, he served as the Director of the company. Mr. Soames also served as the Chief Executive Officer of Serco Group plc between 2014 and 2022. Previously, he served as the Chief Executive of Aggreko plc from 2003 to 2014 and as a Director at DS Smith.

Mr. Deepak Nath has been Chief Executive Officer and Director of the company since 2022. Prior to this, he served as the President of Diagnostics at Siemens Healthineers. He has held various leadership roles in R&D, Marketing, Commercial Divisions including the President of Abbott Vascular and an Executive Officer of Abbott Laboratories from 2007 to 2017. He has worked for Amgen from 2004 to 2007; McKinsey & Company from 2000 to 2004; and at the Lawrence Livermore National Laboratory.

Mr. John Roger has been the Chief Financial Officer and Director of the company since April 2024. Prior to this he served as Non Executive Director & Chair of Audit Committee at Grab.

Ms. Alison Parkes has been the Chief Compliance Officer of the company since 2022. Prior to this, she held various leadership positions in the company including, the Compliance Officer for the Global Advanced Wound Management business from April 2010 to August 2013. Ms. Parkes also served as the Compliance Officer for APAC and Emerging Markets from August 2013 to December 2018; Head of Global Compliance Program Effectiveness & Improvement team; and Technical Information Officer in the AWM UK business.

Mr. Mizanu Kebede has been the Chief Quality and Regulatory Affairs Officer of the company since 2021. Prior to this, he served as the Senior Vice President of Global Quality, Regulatory and Product Safety at Avanos Medical, a spinoff business of Kimberly-Clark Corp. He has held several senior leadership roles within medical devices, diagnostics and healthcare at multinational companies including Life Technologies Corporation, Johnson & Johnson and STERIS Corporation.